Abstract
Alzheimer’s disease affects 50 million people worldwide and just like any modern lifestyle disease, it is steadily increasing. Unfortunately, a cure has not yet been found, despite decades of research. The pathophysiology of Alzheimer’s disease is extraordinarily complex and involves many different factors. Despite it being a protein misfolding disease, a lot of evidence currently point to insulin resistance, impaired glucose metabolism and comorbidities with other metabolic disorders such as obesity, elevated blood lipids, and non-alcoholic fatty liver disease, as a potential root cause. Genetics aside, it seems like poor metabolic functioning affects the brain and central nervous system a great deal: affecting mood, behaviour, and cognitive performance. Even mood disorders are interlinked with metabolic disorders and increase the risk for Alzheimer’s disease later in life. This is a summary of objectively chosen original research articles, published between 2011-2021 and with insulin resistance as the main objective for cognitive impairment and Alzheimer’s disease.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was received for this article.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
N/A
Abbreviations
- AD
- Alzheimer’s Disease
- Aβ
- Amyloid beta
- APP
- Amyloid beta precursor protein
- CBF
- Cerebrospinal blood flow
- CSF
- Cerebrospinal spinal fluid
- CI
- Cognitive impairment
- HPA
- Hypothalamus, Pituitary, Adrenal
- HOMA-IR
- Homeostatic model for insulin resistance
- IGF-1
- Insulin growth factor 1
- IR
- Insulin resistance
- MCI
- Major cognitive impairment
- MDD
- Major depressive disorder
- NAFLD
- Non-alcoholic fatty liver disease
- SSPG
- Steady-state plasma glucose
- T2DM
- Type 2 Diabetes Mellitus
- T1D
- Type 1 Diabetes
- TNF-α
- Tumor necrosis factor alpha
